Damora Therapeutics DMRA
OrbiMed Private Investments VII (Shareholder) plans to sell 109,532 DMRA shares, about $244,804
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0000947871-23-000426
- Approximate sale date: Apr 5, 2023
- Broker: Themis Trading LLC
- Shares acquired by: Private placement
All of OrbiMed Private Investments VII's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 25,220 shares at $2.18 on Apr 5, 2023 · Form 4
- Sold 63,058 shares at $2.18 on Apr 5, 2023 · Form 4
- Sold 6,558 shares at $2 on Apr 6, 2023 · Form 4
- Sold 2,584 shares at $1.79 on Apr 10, 2023 · Form 4
- Sold 703 shares at $1.82 on Apr 11, 2023 · Form 4
- Sold 3,784 shares at $1.82 on Apr 11, 2023 · Form 4
- Sold 641 shares at $1.81 on Apr 12, 2023 · Form 4
- Sold 1,603 shares at $1.81 on Apr 12, 2023 · Form 4
- Sold 703 shares at $1.82 on Apr 13, 2023 · Form 4
- Sold 3,784 shares at $1.82 on Apr 13, 2023 · Form 4
- Sold 660 shares at $1.97 on Apr 17, 2023 · Form 4
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Synlogic SYBX public float $4M, Jun 30, 2025
- Matinas BioPharma Holdings MTNB public float $5M, Jun 30, 2025
- China Pharma Holdings CPHI public float $4M, Jun 30, 2025
- Soligenix SNGX public float $5M, Jun 30, 2025
- Target Group CBDY public float $5M, Jun 30, 2025
